GlassScriptPhysician profile
Kimberly Ott
NPI 1023602141
$4,081.17
in general payments reported to CMS, 2019-2025
45 companies · $2,152 in 2025
The $2,152 reported for 2025 was more than what 94% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $998 · 2024: $799 · 2025: $2,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,850 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,849.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $389.51 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $303.98 | 2023-2025 | Enhertu, Datroway |
| Pfizer INC. | $246.24 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $228.92 | 2022-2025 | Calquence, Enhertu |
| E.R. Squibb & Sons, L.L.C. | $223.88 | 2023-2025 | Opdivo, Opdualag |
| Genzyme Corporation | $182.77 | 2023-2024 | |
| Seagen INC. | $178.27 | 2023 | Adcetris, Padcev |
| Takeda Pharmaceuticals U.S.A., INC. | $175.52 | 2023-2025 | Fruzaqla, Ninlaro |
| Eisai INC. | $156.16 | 2023-2025 | |
| Janssen Biotech, INC. | $138.08 | 2023-2025 | Rybrevant, Darzalex, Imbruvica |
| Novartis Pharmaceuticals Corporation | $124.97 | 2024-2025 | |
| Abbvie INC. | $113.66 | 2024-2025 | |
| Array Biopharma INC | $112.55 | 2023-2025 | Braftovi, Lorbrena, Mektovi |
| Lilly USA, LLC | $107.40 | 2022-2024 | Verzenio, Jaypirca, Retevmo |
| Bayer Healthcare Pharmaceuticals INC. | $106.71 | 2023-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Ott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.